HIGHLIGHTS
- who: Stefano Testa and collaborators from the Department of Medicine, Stanford University, Stanford, CA, USA have published the research: Management of Patients with Newly Diagnosed Desmoid Tumors in a First-Line Setting, in the Journal: Cancers 2022, 3907 of /2022/
- what: Approximately 50% of patients treated with surgery in the study had relapsed at the time of the last follow-up and this must be considered when deciding on primary surgery versus surveillance.
- how: The authors compared outcomes between patients treated with a primary surgical modality and patients managed with either active surveillance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.